Harmonization of Human Biomonitoring in Europe: The European Human Biomonitoring Initiative HBM4EU

摘要

HBM4EU follows an innovative approach to generate the knowledge policy makers need to improve policy in the field of environment and health. Successful chemical policy also relies on sound human biomonitoring data. At the European level data from different countries must be comparable between countries to be used for regulatory purposes at EU level and for elucidating potential regional differences. HBM4EU consists of 109 partner organisations from 28 countries -27 European countries plus Israel - and is organised around 16 work packages led by key players of national HBM studies and research programmes. Major fields of activities are the science policy transfer, Human Biomonitoring (HBM) studies, and research to elucidate the impact of exposure on health. HBM reveals extent and quality of multiple chemicals exposures. Harmonisation is needed at all phases of HBM studies: e.g. study design, data protection and ethical issues, study information materials, informed consent, field work, selection of appropriate biomarkers and matrices, comparability of chemical analysis, QA/QC programs, mixtures, novel biomarkers and screening approaches, sample storage and transport and data analysis. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733032.